PlexusDx GLP-Squared Injection (at $289/mo month-to-month, or from $249/mo on the 6-month plan) combines semaglutide and tirzepatide in one compound, targeting both GLP-1 and GIP receptors for enhanced appetite suppression
Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S
Ibuprofen, meanwhile, can cause dyspepsia, gastric erosion, and peptic ulceration, particularly with prolonged use or in patients with risk factors such as advanced age, previous peptic ulcer disease, or concurrent use of corticosteroids or anticoagulants
For example, if plans receive a 50% rebate on the list price of $1,300 per month (or $15,600 per year), that could mean annual net costs per person around $7,800